Baxion
Screening
Tags
Alerts
Theme
Camp4 Therapeutics Corporation
CAMP
·
NASDAQ
·
$4.10
Share Price as of 11/2
·
$87M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/05/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
09/28/26
8-K
Current report
08/13/26
8-K
Current report
08/04/26
8-K
Current report
07/27/26
8-K
Current report
06/12/26
Prospectuses and Registrations
Filter
424B3
Prospectus
08/12/26
S-3
Shelf registration
08/06/26
S-8
Registration of securities for employees
03/05/26
424B5
Prospectus supplement
12/18/25
FWP
Free writing prospectus
12/18/25
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
DEF 14A
Definitive proxy
04/30/25
DEFA14A
Additional proxy materials
04/30/25
Ownership
Filter
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
08/31/26
SC 13D/A
Beneficial ownership (amended)
08/31/26
Form 4
Insider transaction
08/26/26
Form 4
Insider transaction
08/21/26
Other
Filter
EFFECT
Request for effectiveness
08/12/26
ARS
Annual report to shareholders
04/23/26
ARS
Annual report to shareholders
04/30/25
SEC STAFF LETTER
SEC staff letter
10/16/24
CERT
CEO/CFO certification
10/10/24
Latest Filings
Filter
8-K
Current report
09/28/26
10-Q
Q2 ended 06/30/26
08/13/26
8-K
Current report
08/13/26
424B3
Prospectus
08/12/26
EFFECT
Request for effectiveness
08/12/26
Ownership
Filter
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
08/31/26
SC 13D/A
Beneficial ownership (amended)
08/31/26
Form 4
Insider transaction
08/26/26
Form 4
Insider transaction
08/21/26